Delisting risk
IGC · AMEX · Biotechnology

IGC Pharma

Develops an investigational oral THC-and-melatonin therapy for Alzheimer’s-dementia agitation.

$0.3107
After-hours close+0.00 (+1.04%)
At close$0.3075(−7.91%)
DateEstimateReportedSurprise
Nov 2026−$0.02
Aug 2026−$0.02−$0.03−50.0%
May 2026−$0.02−$0.020.0%
Apr 2026−$0.02−$0.020.0%
Nov 2025−$0.02−$0.020.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
Jun 2025
Feb 2025
Nov 2024
Aug 2024
Jun 2024
Feb 2024
Nov 2023
Jul 2023
Jun 2023
Feb 2023
Nov 2022
Aug 2022
Jun 2022
Feb 2022
Oct 2021
Aug 2021
Jun 2021
Feb 2021
Nov 2020
Aug 2020
Jul 2020
Feb 2020
Nov 2019
Aug 2019
Jun 2019
Feb 2019
Oct 2018
Aug 2018
Jun 2018
Feb 2018
Nov 2017
Aug 2017
Jul 2017
Feb 2017
Nov 2016
Aug 2016
Jul 2016
Feb 2016
Nov 2015
Aug 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 13, 2026−$0.02$164.0K
Aug 14, 2026−$0.02−$0.03−50.0%$164.0K$265.0K+61.6%
May 15, 2026−$0.02−$0.020.0%$198.0K$317.0K+60.1%
Apr 3, 2026−$0.02−$0.020.0%$250.0K$246.5K−1.4%
Nov 14, 2025−$0.02−$0.020.0%$383.0K$191.0K−50.1%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 19, 2025
Jun 30, 2025
Feb 18, 2025
Nov 14, 2024
Aug 8, 2024
Jun 24, 2024
Feb 14, 2024
Nov 9, 2023
Jul 7, 2023
Jun 30, 2023
Feb 14, 2023
Nov 1, 2022
Aug 8, 2022
Jun 22, 2022
Feb 10, 2022
Oct 29, 2021
Aug 11, 2021
Jun 14, 2021
Feb 12, 2021
Nov 20, 2020
Aug 19, 2020
Jul 13, 2020
Feb 10, 2020
Nov 6, 2019
Aug 9, 2019
Jun 17, 2019
Feb 12, 2019
Oct 16, 2018
Aug 2, 2018
Jun 21, 2018
Feb 20, 2018
Nov 20, 2017
Aug 18, 2017
Jul 14, 2017
Feb 21, 2017
Nov 21, 2016
Aug 16, 2016
Jul 14, 2016
Feb 16, 2016
Nov 13, 2015
Aug 17, 2015